Min Kwan-Hong Christopher 4
4 · Longeveron Inc. · Filed Apr 6, 2022
Insider Transaction Report
Form 4
Longeveron Inc.LGVN
Min Kwan-Hong Christopher
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-04-04+50,000→ 50,000 totalExercise: $12.85Exp: 2032-04-03→ Common stock (50,000 underlying) - Award
Common stock
2022-04-04+2,335→ 2,335 total - Award
Common stock
2022-04-04+150,000→ 152,335 total - Award
Stock Option (right to buy)
2022-04-04+2,335→ 2,335 totalExercise: $12.85Exp: 2032-04-03→ Common stock (2,335 underlying)
Footnotes (6)
- [F1]Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
- [F2]Includes 2,335 Restricted Stock Units.
- [F3]Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year.
- [F4]Includes 152,335 Restricted Stock Units.
- [F5]The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
- [F6]The option vests ratably 25% each year.